{"id":"NCT00845065","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED)","officialTitle":"A Phase 3 Safety and Efficacy Study of Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2009-02-16","resultsPosted":"2012-02-02","lastUpdate":"2017-04-07"},"enrollment":202,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C, Chronic"],"interventions":[{"type":"DRUG","name":"Boceprevir","otherNames":["SCH 503034"]},{"type":"OTHER","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Peginterferon alfa-2a","otherNames":["PegasysÂ®"]},{"type":"DRUG","name":"Ribavirin","otherNames":["SCH 18908"]}],"arms":[{"label":"Arm 1 (Control Arm)","type":"PLACEBO_COMPARATOR"},{"label":"Arm 2 (Boceprevir Arm)","type":"EXPERIMENTAL"}],"summary":"Based on previous experience with peginterferon alfa-2b/ribavirin in combination with boceprevir, the combination with peginterferon alfa-\n\n2a/ribavirin and boceprevir is expected to be safe and well tolerated. Given the wide utilization of both peginterferons and the clear benefit of the\n\naddition of boceprevir to peginterferon alfa-2b/ribavirin, it is important to demonstrate the safety and efficacy of boceprevir in combination with\n\npeginterferon alfa-2a/ribavirin.","primaryOutcome":{"measure":"Sustained Virologic Response (SVR) Rate in Full Analysis Set (FAS) Population.","timeFrame":"Follow-up Week 24","effectByArm":[{"arm":"PEG2a/Ribavirin","deltaMin":20.9,"sd":null},{"arm":"Boceprevir/PEG2a/Ribavirin","deltaMin":64.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":18},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["23064222"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":67},"commonTop":["FATIGUE","ANAEMIA","NAUSEA","DYSGEUSIA","HEADACHE"]}}